HHQ16, an orally active derivative of Astragaloside IV, effectively reverses infarction-induced hypertrophy and heart failure by targeting and degrading lnc4012/lnc9456 and antagonizing their effects on G3BP2/NF-kappaB signaling.
Molecular Weight:
510.7
CAS Number:
[2620471-66-9]
Formula:
C30H48F2O4
* VAT and and shipping costs not included. Errors and price changes excepted
